Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
RTNominal up1.490 +0.050 (+3.472%)

08/10/2021 10:34

Sihuan Pharm (00460) repurchases 1 million shares

[ET Net News Agency, 8 October 2021] Sihuan Pharmaceutical Holdings Group Ltd. (00460)
said on 7 October 2021, the company repurchased, pursuant to the repurchase mandate, a
total of 1,000,000 shares of the company on market at an average price of HK$1.6565 per
The aggregate purchase price paid (excluding commission and other expenses) was
approximately HK$1,656,500. The repurchased shares represent approximately 0.01% of the
total number of issued shares. (RC)

Remark: Real time quote last updated: 07/12/2021 16:49
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.